Table 3 Different therapies and outcomes of UTROSCT patients reported in the literature (2014 ~ 2023)
Present cases | No | Year | Age | Outcome (follow-up) |
|---|---|---|---|---|
Hysterectomy ± bilateral salpingo-oophorectomy | ||||
Gutierrez-Pecharroman, et al. [10] | 1 | 2014 | 49 | Ned (18 months) |
Bakula-Zalewska, et al. [6] | 4 | 2014 | 50–63 | Ned (3–14.5 years) |
Moore, et al. [7] | 31 | 2017 | 26–86 | 7/31 recurrence (6–135 months) |
Kondo, et al. [11] | 1 | 2018 | 63 | 1/1 recurrence (6 years) |
Croce, et al. [12] | 1 | 2019 | 72 | 1/1 recurrence (17 months) |
Dubruc, et al. [13] | 1 | 2019 | 56 | Ned (4 months) |
Zhang, et al. [14] | 2 | 2019 | 33, 64 | Ned (12 days–1 year) |
Lee, et al. [15] | 2 | 2019 | 34, 47, 59 | Ned (116 months–20 years) |
Vilos, et al. [16] | 2 | 2019 | 47, 52 | Ned (1–3 years) |
Dimitriadis, et al. [17] | 1 | 2020 | 46 | 1/1 recurrence (2 years) |
Grither, et al. [18] | 1 | 2020 | 69 | Ned (8 months) |
Chang, et al. [19] | 1 | 2020 | 57 | 1/1 recurrence (30 months) |
Bennett, et al. [20] | 3 | 2020 | 32, 37, 54 | 3/3 recurrence (7–32 years) |
Kaur, et al. [21] | 5 | 2020 | 42–50 | 1/5 recurrence (1 month–2 years) |
Goebel, et al. [22] | 10 | 2020 | 34–74 | 1/10 recurrence (1–319 months) |
Zhou, et al. [8] | 1 | 2021 | 51 | Ned (58 months) |
Devereaux, et al. [23] | 1 | 2021 | 42 | 1/1 recurrence (6 months) |
Shibahara, et al. [24] | 1 | 2022 | 77 | Ned (12 months) |
Wang, et al. [3] | 1 | 2022 | 42 | Ned (2 months) |
Pang, et al. [25] | 2 | 2022 | 42, 46 | Ned (4–35 months) |
Ye, et al. [2] | 4 | 2022 | 40–70 | Ned (uncertain) |
Zhou, et al. [26] | 1 | 2023 | 49 | Ned (1 months) |
Lu, et al. [27] | 11 | 2023 | 37–60 | Ned (11–141 months) |
Radical surgery | ||||
Umeda, et al. [28] | 2 | 2014 | 38, 57 | Ned (11 months–8 years) |
Mačák, et al. [29] | 1 | 2015 | 53 | Ned (10 months) |
Cetinkaya, et al. [30] | 1 | 2016 | 52 | Ned (17 months) |
Kuznicki, et al. [31] | 1 | 2017 | 49 | Death (15 months) |
Fan, et al. [32] | 1 | 2018 | 62 | Ned (20 days) |
Segala, et al. [33] | 1 | 2019 | 62 | Ned (5 years) |
Sato, et al. [34] | 1 | 2020 | 57 | Ned (3 years) |
Conservative treatment | ||||
Bakula-Zalewska, et al. [6] | 2 | 2014 | 24,25 | Ned (4.5–7 years) |
Watrowski, et al. [35] | 1 | 2015 | 22 | Ned (28 months) |
Jeong, et al. [36] | 1 | 2015 | 32 | Ned (47 months) |
De Franciscis, et al. [37] | 1 | 2016 | 38 | Ned (60 months) |
Moore, et al. [7] | 2 | 2017 | 12, 36 | Ned (27–63 months) |
Schraag SM, et al. [38] | 2 | 2017 | 24, 28, 72 | 2/2 recurrence (6–39 months) |
Lee, et al. [15] | 1 | 2019 | 34 | Ned (49 months) |
Goebel, et al. [22] | 1 | 2020 | 38 | Ned (50 months) |
Carbone, et al. [39] | 2 | 2021 | 25, 30 | Ned (96 months,16 months) |
Ye, et al. [2] | 1 | 2022 | 40 | Ned (uncertain) |
Lu, et al. [27] | 6 | 2023 | 27–50 | Ned (17–55 months) |